For tamoxifen-resistant MCF-7 cells, one proteome report demonstrated that tamoxifen-resistant breast cancer cells are characterized by downregulated ER signaling, the activation of alternative survival pathways, and enhanced cell motility, including RhoA protein [39]. The gene discussed is RHOA; the disease is breast carcinoma.